Orgametril (Lynestrenol)

Lynestrenol exerts its effect by binding to progesterone receptors, suppressing the luteinizing hormone surge, which prevents ovulation. It also induces changes in the endometrium and thickens cervical mucus, creating an environment that is unfavorable for fertilization and implantation.

The specific dose and regimen of Orgametril are determined by the prescribing healthcare professional based on the patient’s clinical needs and the intended indication. Typically, the medication is taken orally once daily as part of a cyclic schedule, but exact details must be provided by the prescriber.

Orgametril is contraindicated in pregnancy because it is intended to prevent conception. Its safety during breastfeeding has not been fully established; therefore, a healthcare provider should evaluate the risks and benefits before use in lactating women.

To order Orgametril, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Compared with other progestogen‑only pills such as levonorgestrel, lynestrenol offers a similar mechanism of ovulation suppression but may differ in side‑effect profiles and dosing schedules. The choice between products depends on individual patient factors, tolerance, and the prescriber’s clinical judgment.

Orgametril tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children.

Orgametril is taken orally, usually as a single tablet each day. It is commonly prescribed in a cyclic regimen (e.g., 21 days of active tablets followed by a hormone‑free interval), but the exact schedule should follow the prescriber’s instructions.

The most serious risks include thromboembolic events such as deep‑vein thrombosis or pulmonary embolism, severe allergic reactions, and hepatic dysfunction. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Orgametril should not be used by women who are pregnant, have a known hypersensitivity to lynestrenol or any tablet excipients, have active liver disease, a history of thromboembolic disorders, or who are currently using interacting medications that could reduce its effectiveness.